1. Home
  2. JYNT vs ENTA Comparison

JYNT vs ENTA Comparison

Compare JYNT & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JYNT
  • ENTA
  • Stock Information
  • Founded
  • JYNT 2010
  • ENTA 1995
  • Country
  • JYNT United States
  • ENTA United States
  • Employees
  • JYNT N/A
  • ENTA N/A
  • Industry
  • JYNT Multi-Sector Companies
  • ENTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • JYNT Miscellaneous
  • ENTA Health Care
  • Exchange
  • JYNT Nasdaq
  • ENTA Nasdaq
  • Market Cap
  • JYNT 170.1M
  • ENTA 164.6M
  • IPO Year
  • JYNT 2014
  • ENTA 2013
  • Fundamental
  • Price
  • JYNT $11.60
  • ENTA $6.57
  • Analyst Decision
  • JYNT Strong Buy
  • ENTA Buy
  • Analyst Count
  • JYNT 2
  • ENTA 4
  • Target Price
  • JYNT $15.50
  • ENTA $18.00
  • AVG Volume (30 Days)
  • JYNT 73.1K
  • ENTA 157.6K
  • Earning Date
  • JYNT 08-07-2025
  • ENTA 08-04-2025
  • Dividend Yield
  • JYNT N/A
  • ENTA N/A
  • EPS Growth
  • JYNT N/A
  • ENTA N/A
  • EPS
  • JYNT N/A
  • ENTA N/A
  • Revenue
  • JYNT $52,789,479.00
  • ENTA $64,462,999.00
  • Revenue This Year
  • JYNT $9.48
  • ENTA N/A
  • Revenue Next Year
  • JYNT $11.15
  • ENTA $0.48
  • P/E Ratio
  • JYNT N/A
  • ENTA N/A
  • Revenue Growth
  • JYNT 71.05
  • ENTA N/A
  • 52 Week Low
  • JYNT $9.58
  • ENTA $4.09
  • 52 Week High
  • JYNT $15.32
  • ENTA $17.24
  • Technical
  • Relative Strength Index (RSI)
  • JYNT 54.97
  • ENTA 45.50
  • Support Level
  • JYNT $11.71
  • ENTA $6.95
  • Resistance Level
  • JYNT $12.27
  • ENTA $8.23
  • Average True Range (ATR)
  • JYNT 0.62
  • ENTA 0.40
  • MACD
  • JYNT -0.01
  • ENTA -0.10
  • Stochastic Oscillator
  • JYNT 46.05
  • ENTA 7.42

About JYNT The Joint Corp.

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has two operating business segments; the Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics, and The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The company generates maximum revenue from the Corporate clinic's segment.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

Share on Social Networks: